Skip to main content
Investigative Ophthalmology & Visual Science logoLink to Investigative Ophthalmology & Visual Science
. 2018 Apr;59(5):2015–2023. doi: 10.1167/iovs.17-23705

Long Anterior Lens Zonules and Intraocular Pressure

Daniel K Roberts 1,2,3, Tricia L Newman 1, Mary Flynn Roberts 1, Bruce A Teitelbaum 1, Janis E Winters 1
PMCID: PMC5907516  PMID: 29677364

Abstract

Purpose

To investigate the relation between intraocular pressure (IOP) and the idiopathic long anterior zonule (LAZ) trait.

Methods

Patients presenting for primary eye care were examined for LAZ, identified as radially oriented zonular fibers with central extension >1.0 mm beyond the normal anterior lens insertion zone (estimated via slit lamp beam length). Ocular, systemic health, and lifestyle data were collected via comprehensive exam and questionnaire. Multivariate regression was used to assess the relationship between IOP (Goldmann) and LAZ.

Results

There were 2169 non-LAZ and 129 LAZ subjects (mean age: 49.8 ± 15.0 vs. 62.6 ± 10.2 years; 63.6% vs. 76.0% female; 83.2% vs. 91.5% African American). Right eyes with >trace LAZ (n = 59 of 110) had higher unadjusted mean IOP than control eyes (16.4 ± 3.3 vs. 15.0 ± 3.3 mm Hg, P = 0.005), and with control for numerous factors, LAZ eyes had an average IOP of approximately 1.3 ± 0.4 mm Hg higher (P = 0.003) than non-LAZ eyes. Final model covariates included sex (P = 0.001); spherical-equivalent refractive error (D; P < 0.0001); body mass index (kg/m2; P < 0.001); presence of diabetes (P < 0.001); having >high school education (P < 0.001); systolic blood pressure (mm Hg; P < 0.0001); being an ever smoker (P = 0.006); and having history of any site cancer (P = 0.01).

Conclusions

The LAZ trait, with potential prevalence near 2%, was associated with a higher IOP. This observation is consistent with the hypothesis that the trait is a marker for underlying mechanisms that elevate glaucoma risk.

Keywords: crystalline lens, glaucoma, intraocular pressure, long anterior zonules, pigment dispersion


Long anterior zonules (LAZ) are characterized by zonular fibers that extend more central than usual on the anterior lens capsule.14 They are observed following pupillary dilation as radially oriented fine lines, which often become pigmented due to rubbing against the posterior iris pigment epithelium (Figs. 1, 2). Other pigment dispersal signs may also be present, including Krukenberg spindles and trabecular meshwork pigmentation,57 and these signs may cause LAZ-associated pigment dispersion to be confused with the more well-known “classic” variety pigment dispersion syndrome.8,9

Figure 1.

Figure 1

Example of normal zonule insertion (top) and LAZ (bottom). Persistent pupillary membrane iris strand, common with LAZ, is also shown (bottom, asterisk).

Figure 2.

Figure 2

Example of pigmented LAZ.

Current understanding suggests that the LAZ trait may present with at least two phenotypic varieties. One rare variety may be detected during a young age, which occurs with a serine to arginine (S163R) substitution in the complement 1q tumor necrosis factor-related protein 5 (C1QTNF5) gene that causes late-onset retinal degeneration (L-ORD).10,11 Another, more common variety with unknown etiology and prevalence possibly near 2%,12 has association with age >50 years,4,6,12 female sex,4,6,12 hyperopia,6,12,13 shorter axial length,14 and persistent pupillary membrane iris strands.15 Only recently has the literature begun to differentiate between these separate LAZ presentations, and it's unknown what pathophysiology may produce LAZ in such different groups.

The LAZ trait has also drawn interest relative to cataract surgery because the anomalous fibers reduce the size of the anterior capsule's zonule-free zone (ZFZ), creating concern that zonular cutting during capsulorhexis may elevate risk of capsular tearing and intraocular lens dislocation.1624 Furthermore, there has also been suggestion that the LAZ trait could signal higher risk for both open- and narrow-angle glaucoma.5,7,10,14,25,26 In 1962, Stankovic and Stankovic26 reported 14 subjects who had LAZ and pigment dispersal signs, with nine having heavy trabecular meshwork pigmentation and elevated IOP. Similarly, Moroi et al.5 described 15 LAZ subjects with pigment dispersion signs, seven of whom were being treated for glaucoma or ocular hypertension. About half belonged to a four-generation pedigree (UM:H389)7 that had many members exhibiting LAZ alone or LAZ with the autosomal dominant retinal condition mentioned earlier called L-ORD.10,11 The C1QTNF5 gene, which has the S163R mutation causing L-ORD, maps to chromosome 11q23 and influences wide-ranging processes that include cellular adhesion and basement membrane functions.27,28

The question of increased risk of angle-closure glaucoma is perhaps not surprising given that people with late-onset LAZ are more likely to be older, hyperopic, and female. However, it's not clear that angle-closure risk is any higher among people with LAZ than among similar people with similar refractive error who don't have LAZ.29 There has also been question though as to whether there is association between LAZ and plateau iris configuration.25 Should this be the case, potential angle-closure risk could be more complex than any risk conveyed by basic axial dimensions of the eye.

Given the potential relationship between LAZ and glaucoma, there is need for further inquiry, and as a step toward this, we investigated whether we could detect a relationship between the LAZ trait and IOP level.

Methods

As part of a larger investigation of ocular and general health associations with the LAZ trait, consecutive patients, presenting to six different practitioners for a regularly scheduled examination in an urban academic eye care facility in Chicago, Illinois, were included as subjects if they were aged ≥18 years, having their pupils dilated, and if they provided informed consent and completed a brief written questionnaire to supplement other demographic, health, and lifestyle information. Along with ocular/medical histories, assessment included testing of Snellen visual acuities, pupils, motility and binocularity, color vision, and confrontation visual fields. Also done were predilation subjective refraction, slit lamp exam, Goldmann applanation tonometry, and dilated retinal exam.

Student clinicians within the facility's Primary Eye Care Service performed initial testing on subjects. Although tonometry was often checked by attending faculty investigators, student measurements were used for analysis because faculty measurements were not always done. Single measurements obtained on the day of study were used and all were performed in a consistent fashion using slit lamp mounted Goldmann tonometers, the standard in this clinical setting.

Immediately after instillation of pupil dilation drops, student clinicians provided questionnaires for completion without assistance. Faculty investigators learned of subject participation at time of final physical assessment and then examined for LAZ using bright slit-lamp illumination with ×16 to ×25 magnification. Investigators were experienced in LAZ detection from prior investigations.6,13,15,23,30

The criterion for LAZ was presence of radially oriented zonular fibers, pigmented or nonpigmented, with anterior tips judged to extend substantially (>1.0 mm, estimated with slit-lamp beam length) central to the normal capsular zonular insertion zone, about 1.5 mm anterior to the lens equator.31 From their anterior tips, LAZ fibers could extend peripherally to the dilated pupil border where they became obscured, or the fibers could be “segmental”32 whereby their peripheral tips stopped abruptly along the anterior capsule without detectable extension to the pupil border (Fig. 3). We included subjects with any degree (number) of LAZ, but also distinguished between <5 LAZ fibers (trace LAZ) and five or more detectable fibers.23

Figure 3.

Figure 3

“Segmental” type LAZ, characterized by LAZ fibers that end abruptly without peripheral extension all the way to the dilated pupil border (arrows). Persistent pupillary membrane iris strand is also shown (asterisk).

In addition to LAZ, investigators examined eyes for Krukenberg spindles and persistent pupillary iris strands.6,12,15 We considered a Krukenberg spindle present when there was any “fine pigment dusting” along the central posterior cornea, which we considered present when individual pigment granules could not be “counted” because they were too fine, numerous, and coalesced. Larger, coarse pigment flecks were not considered a sign of a Krukenberg spindle. We considered persistent pupillary membrane iris strands (Figs. 1, 3) present when there was at least one iris strand that bisected the dilated pupil and had both ends attached to the iris collarette or one end to the collarette and the other to the anterior lens capsule.15

We determined race using medical record notation and the questionnaire, and assigned one of five categories: (1) black/African American, (2) Asian, (3) Hispanic, black or white, (4) Non-Hispanic white, and (5) Other. Education level was determined via questionnaire by asking: “What is your highest level of education? (1) Less than high school degree, (2) High school degree, (3) Vocational school or some college but no degree, (4) College Associate's or Bachelor's degree, (5) College Master's, Professional, or Doctoral degree.”

We also used the questionnaire to categorize subjects as a “current smoker,” “former smoker,” or “never smoker” by asking: “Have you ever been a smoker? (1) Yes, currently, (2) Previously: quit <12 months ago, (3) Previously: quit >12 months ago, (4) Never or rarely: smoked less than a total of 50 cigarettes (2½ packs) over my lifetime.” To improve categorization, we asked subjects what they had smoked and how much, the age started, and when they had stopped.

For alcohol use, we used the questionnaire to categorize subjects as a “current drinker,” “former drinker,” or “never drinker” by asking: “Do you drink alcohol? (1) Yes, I do currently, (2) Previously: quit <12 months ago, (3) Previously: quit >12 months ago, (4) Never or rarely because I have not drunk alcohol more than 10 times during my life.” To improve categorization, we asked subjects how many days per week they drank, how many years, and when they had stopped drinking.

For diabetes and hypertension, we considered subjects as having these conditions if they were taking medication at the time of exam or if they had stopped against medical advice. In addition to assessing formal hypertension diagnosis, student clinicians measured blood pressure with automated wrist cuffs or manual arm sphygmomanometers prior to eye drop instillation for pupillary dilation. Body mass index (BMI) was derived using weight and height (kg/m2) collected via the questionnaire, and it was explored as a continuous variable and using standard BMI categories for adults.33 We explored cholesterol lowering medications using two approaches: via the medication list in the health record and by asking about a history of high cholesterol and medication use via the questionnaire.

To assess potential confounding, we also collected information on concurrent use of oral beta-blockers, as well as oral, inhaled, or topical corticosteroids. Since subjects often could not recall specific medication names, we conducted subanalyses that excluded subjects with “unknown” hypertensive medications.

For refractive error, we used spherical-equivalent (SE) values based on the noncycloplegic, predilation subjective refraction, and we excluded eyes with history of refractive surgery or condition that could influence refractive error. Also, we excluded eyes with history of trauma, uveitis, intraocular surgery, or other condition if there was likely influence on IOP. Eyes treated with IOP-lowering medications for glaucoma or ocular hypertension were excluded to eliminate artificial influence on IOP.

After analysis of the current data, we also analyzed an older dataset (collected 1999–2001) previously used to study LAZ.6,12 Although the older dataset did not contain as many variables as the current, we checked for trends similar to current data (see Supplementary Material for further discussion).

Statistical analyses were conducted using a commercial system (SAS Release 9.3 for Microsoft Windows; SAS Institute, Inc., Cary, NC, USA). In addition to descriptive statistics, multiple linear regression was used to model independent variables against the dependent variable, IOP. Model building was aided by stepwise, forward, and backward regression techniques, and variables were explored using varied continuous and categorical formats as appropriate. Assumptions were met for analyses, and variables were checked for correlation and interaction. The investigation received Institutional Review Board approval, the research followed the tenets of the Declaration of Helsinki, and subjects provided written informed consent prior to participation.

Results

Among 3654 total potential subjects, 2740 (75.0%) consented (Fig. 4). Sex proportion was similar between those consenting and not (female: 64.2% vs. 65.0%; P = 0.65), but mean age of consenters was slightly younger (52.1 ± 15.8 vs. 55.0 ± 17.0 years; P < 0.0001). Race distribution was heavily skewed toward African Americans, and a slightly higher percentage of African Americans consented compared to non-African Americans (75.8% vs. 70.9%, P = 0.009).

Figure 4.

Figure 4

Flow diagram summarizing selection of subjects.

For final regression analyses, 442 (16.1%) of the 2740 consenting subjects were excluded due to one or more of the following: (1) both eyes had a history of ocular surgery, injury, uveitis, or other condition that might influence IOP; (2) LAZ presence could not be assessed in either eye because of pseudophakia, insufficient pupillary dilation, etc.; (3) LAZ were absent in one eye, but couldn't be ruled out in the other eye because it couldn't be assessed; (4) glaucoma medications were being taken; and/or (5) there was missing information. This left 2298 subjects.

Among consenters, 163 of 2740 (5.9%) had LAZ of any degree (including trace LAZ, i.e., <5 fibers) in at least one eye. Of these, 109 (66.8%) had bilateral LAZ, 27 (16.6%) had only right eye LAZ, and 27 (16.6%) had only left eye LAZ. Mean age of the 163 LAZ subjects was 63.7 ± 11.2 years (36–92 years), and 73.0% were female. Reflecting institutional demographics, LAZ subjects were predominantly African American (92.0%), with some being Hispanic (3.7%), white (3.1%), and other (1.2%).

Of the 163 total LAZ subjects, we excluded 34 (61.8% female, mean age = 68.2 ± 13.8 years, 38–92 years) for the aforementioned reasons, leaving 129 inclusions (76.0% female, mean age = 62.6 ± 10.2 years, 36–91 years) for final analyses. Race distribution of the 129 LAZ inclusions was 118 (91.5%) African Americans; 5 (3.9%) Hispanics; 4 (3.1%) whites; and 2 (1.6%) subjects of other race. Of the 34 LAZ exclusions, there were 32 (94.1%) African Americans; 1 (2.9%) Hispanic; and 1 (2.9%) white.

Composition of the 2169 non-LAZ inclusions was 63.6% female (mean age = 49.8 ± 15.0 years, 18–94 years), and race distribution was 83.2% African American, 7.3% Hispanic, 6.0% white, 1.7% Asian, and 1.8% other. Composition of the 408 non-LAZ exclusions was 63.6% female (mean age = 59.8 ± 16.8 years, 18–95 years), and race distribution was 83.4% African American, 8.1% Hispanic, 5.1% white, 1.5% Asian, and 2.0% other.

Among all LAZ subjects, 18 of 163 (11.0%) were using IOP-lowering medication (95% bilaterally) for diagnosed glaucoma or ocular hypertension. Of the non-LAZ subjects who consented, 135 of 2577 (5.2%) were using IOP medication (90% bilaterally). Therefore, use of IOP medication was a frequent reason for exclusion among the 34 LAZ and 408 non-LAZ exclusions.

Prior to multivariate analysis, using just right eyes, we calculated unadjusted relationships between LAZ and IOP and between IOP and other potential confounding/explanatory variables. We also calculated unadjusted relationships between LAZ and the other potential confounding/explanatory variables (Tables 14). To explore whether relationships varied with degree of LAZ, we performed analyses with and without eyes having only trace LAZ (i.e., <5 LAZ fibers). As shown in Tables 1 and 2, there were numerous unadjusted relationships with the LAZ trait, which sometimes varied depending on inclusion of the trace LAZ eyes. As indicated, those with trace LAZ were younger on average compared to those with >trace LAZ (i.e., 60.8 vs. 65.1 years).

Table 1.

Univariate Associations With LAZ, Categorical Variables

graphic file with name i1552-5783-59-5-2015-t01.jpg

Table 2.

Univariate Associations With LAZ, Continuous Variables

graphic file with name i1552-5783-59-5-2015-t02.jpg

Table 3.

Univariate Relationships With IOP, Categorical Variables

graphic file with name i1552-5783-59-5-2015-t03.jpg

Table 4.

Univariate Correlations With IOP, Continuous Variables

graphic file with name i1552-5783-59-5-2015-t04.jpg

As shown in Tables 3 and 4, numerous variables, as well as having >trace LAZ, showed significant relationship to IOP. Unadjusted mean IOP among eyes with >trace LAZ was higher compared to eyes without LAZ (i.e., 16.4 ± 3.3 vs. 15.0 ± 3.3 mm Hg; P = 0.005). There was no significant difference between eyes with only trace LAZ and eyes without LAZ (i.e., 14.7 ± 3.7 vs. 15.0 ± 3.3 mm Hg; P = 0.55). Using multivariate modeling to explore the LAZ-IOP relationship with control for other variables, a relationship between >trace LAZ and IOP persisted (P = 0.003; Table 5), with the LAZ coefficient estimate indicating that on average, IOP was about 1.3 ± 0.4 mm Hg higher in eyes with LAZ versus eyes without.

Table 5.

Multivariate Analysis of LAZ Relationship With IOP, Controlling for Other Variables

graphic file with name i1552-5783-59-5-2015-t05.jpg

Table 6 shows how analyses varied with and without inclusion of the trace LAZ eyes. As shown, the LAZ-IOP relationship was reduced with inclusion of trace LAZ eyes (n = 110, coefficient = 0.61 ± 0.32, P = 0.06) and it disappeared when only trace LAZ eyes were included (n = 51, coefficient = −0.17 ± 0.46, P = 0.71).

Table 6.

Multivariate Analysis of LAZ With IOP, Controlling for Other Variables; Stability of Coefficient Estimates Among LAZ Eye Subgroups

graphic file with name i1552-5783-59-5-2015-t06.jpg

Along with primary analyses of right eyes, we also checked for stability and consistency in the LAZ-IOP relationship using other groupings of LAZ eyes (Table 6). Results remained consistent when the LAZ eyes included only left eyes with >trace LAZ (n = 59, coefficient = 1.07, P = 0.008), as well as only African American right eyes with >trace LAZ (n = 56, coefficient = 1.43, P = 0.002). Finally, although numbers of eyes were greatly reduced, we also assessed subjects presenting for first-time facility visits. Despite fewer subjects, (>trace LAZ right eyes, n = 8; control right eyes, n = 870) and loss of statistical power, results were consistent for a LAZ-IOP relationship (n = 8 LAZ, coefficient = 2.1, P = 0.08).

Similar to the current dataset, analysis of the older dataset6,12 yielded results that also supported a LAZ-IOP relationship while providing reasonable control for other variables (see Supplementary Material).

Discussion

This analysis supports a relationship between IOP level and LAZ, and indicated that IOP was about one mm Hg higher, or more, on average among eyes with LAZ compared to non-LAZ eyes. Although this may seem a modest average amount, effect size could be larger in individual subjects. Also, it should be kept in mind that lowering of IOP by just 1 mm Hg yielded 10% risk reduction in visual field deterioration in the Early Manifest Glaucoma Trial34 as well as a 10% reduced risk of conversion to overt glaucoma in the Ocular Hypertension Treatment Trial.35 Given that LAZ subjects taking glaucoma medications were excluded, the magnitude of association could be larger than estimated herein.

It should be emphasized that our goal was not to perform an exhaustive analysis of factors that might have association with IOP, but rather to explore the LAZ-IOP relationship while providing reasonable control for other variables. In assessing the control provided by our statistical models, it's also appropriate to gauge whether the control factor relationships are compatible with previous investigations. Although reports vary relative to populations studied, definition of variables, and other methodologic considerations, our data appear generally consistent with reported directional relationships to IOP in terms of age,3638 sex,37,38 myopia,3739 body mass index,37,38,4042 systolic blood pressure,3638,4345 diabetes,44,46,47 and education level/socioeconomic status.48

Although certain studies have noted a positive relationship between “current smoking” and IOP,49,50 others have not.4042 We found (Table 3) an unadjusted mean IOP = 14.9 ± 3.3 mm Hg among both “current smokers” (32% of subjects) and “past smokers” (19% of subjects). Whereas the dichotomous variable “current smoker versus past/never smoker” did not reach statistical significance in final models (P > 0.05), “ever smoker versus never smoker” did reach significance (P = 0.006, Table 5). Thus, selection of “ever smoker” instead of “current smoker” may simply have added greater statistical power in final models. Factors related to the negative association between smoking and IOP in our study may be related to our clinic-based population demographics.

To our knowledge, the inverse association we measured between IOP and history of any type cancer has not been previously reported,5155 and we could only speculate why this relationship was present, especially since “cancer” represents a heterogenous collection of diseases with varied treatments. Certainly, there could be a “survivor effect” or some other selection bias influencing this observation.

It is not our intent in this report to conclude that the LAZ trait has a direct effect on IOP, nor that it's absolutely a risk factor for glaucoma. Such conclusions are beyond the scope of this cross-sectional study. Nonetheless, the findings herein are important because they are consistent with anecdotal reports that a LAZ-IOP/glaucoma relationship may exist.5,7,10,26 Should the trait prove to be a risk factor for elevated IOP and glaucoma, mechanisms are currently unknown. Although LAZ fibers can rub against the posterior iris and lead to pigment dispersion,2,4,5 it is not evident that pigment granule effects on aqueous outflow are typically sufficient to influence IOP.

A weakness of this report is that subjects were not fully representative across multiple race/ethnicities. It is a goal to broaden this inquiry for generalizability since it's clear that LAZ prevalence may be similar across many racial/ethnicities.6

Also, in this study it was not possible to mask determination of LAZ status to IOP because the faculty investigators had to review student exam findings prior to the postdilation lens assessment. However, it was not an initial goal of data collection to specifically compare IOP between LAZ and non-LAZ subjects. Thus, it seems unlikely that detection of LAZ was influenced by IOP status. Nonetheless, it is also a goal of future studies to further reduce potential bias in this regard.

Although we did not have central corneal thickness (CCT) measures, the corneal thickness-LAZ relationship has been studied in our population. In that study, mean CCT was similar between 61 African Americans and controls matched on age, race, and sex (LAZ versus control right/left eyes: 535 ± 31 vs. 535 ± 36 μm/526 ± 29 vs. 529 ± 36 μm).14 By definition, for a factor to be a confounder, it must have significant association with the dependent (IOP) and independent variables of interest (LAZ). Thus, without evidence that CCT has relationship with LAZ, it seems unlikely that the LAZ-IOP association detected is confounded by CCT. Nonetheless, it is also a goal to establish this further.

Since this work has investigated IOP, it would be ideal if gonioscopy had been done on all eyes to absolutely rule out narrow angle and other anomalous contribution to IOP level. However, gonioscopy was performed when van Herick estimation suggested the need to verify angle openness prior to proceeding with pupillary dilation. In addition, gonioscopy was performed on subjects with IOP >21 mm Hg, and subjects identified with partial angle-closure were excluded from analysis. It therefore seems unlikely that undiscovered angle-closure mechanisms were responsible for the LAZ-IOP association found in this current investigation.

Conclusions

In this analysis, the LAZ trait was associated with a higher IOP compared to eyes without LAZ. This is consistent with hypothesis that LAZ may be a marker for underlying mechanisms that elevate glaucoma risk. Given its potential prevalence, the idiopathic LAZ trait should be studied further.

Supplementary Material

Supplement 1

Acknowledgments

The authors thank David Castells for contribution to the collection of subject data.

Supported by National Eye Institute Grant K23 EY0181883 (DKR).

Disclosure: D.K. Roberts, None; T.L. Newman, None; M.F. Roberts, None; B.A. Teitelbaum, None; J.E. Winters, None

References

  • 1. Bellows JG. . Pigmented lines in retroiridal region of anterior capsule of lens. Arch Ophthalmol. 1944; 32: 483– 484. [Google Scholar]
  • 2. Larsen FE, Hvidberg J. . Vogt's retro-iridian pigment lines. Light microscopical and ultrastructural study of a case. Acta Ophthalmol (Copenh). 1976; 54: 641– 653. [DOI] [PubMed] [Google Scholar]
  • 3. Rieger G. . Radial retroiridal linear pigmentation. Br J Ophthalmol. 1981; 65: 760– 761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Sturrock GD, Tripathi RC. . Pigmented lens striae. Br J Ophthalmol. 1976; 60: 287– 293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Moroi SE, Lark KK, Sieving PA,et al. Long anterior zonules and pigment dispersion. Am J Ophthalmol. 2003; 136: 1176– 1178. [DOI] [PubMed] [Google Scholar]
  • 6. Roberts DK, Winters JE, Castells DD, Teitelbaum BA, Alexander CC. . A cross-sectional study of Krukenberg spindles and pigmented lens striae in a predominately black population: two highly associated clinical signs of anterior segment pigment dispersal. J Glaucoma. 2005; 14: 57– 63. [DOI] [PubMed] [Google Scholar]
  • 7. Ayyagari R, Griesinger IB, Bingham E, Lark KK, Moroi SE, Sieving PA. . Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene. Arch Ophthalmol. 2000; 118: 85– 92. [DOI] [PubMed] [Google Scholar]
  • 8. Campbell DG. . Pigmentary dispersion and glaucoma. A new theory. Arch Ophthalmol. 1979; 97: 1667– 1672. [DOI] [PubMed] [Google Scholar]
  • 9. Karickhoff JR. . Pigmentary dispersion syndrome and pigmentary glaucoma: a new mechanism concept, a new treatment, and a new technique. Ophthalmic Surg. 1992; 23: 269– 277. [PubMed] [Google Scholar]
  • 10. Ayyagari R, Mandal MN, Karoukis AJ,et al. Late-onset macular degeneration and long anterior lens zonules result from a CTRP5 gene mutation. Invest Ophthalmol Vis Sci. 2005; 46: 3363– 3371. [DOI] [PubMed] [Google Scholar]
  • 11. Subrayan V, Morris B, Armbrecht AM, Wright AF, Dhillon B. . Long anterior lens zonules in late-onset retinal degeneration (L-ORD). Am J Ophthalmol. 2005; 140: 1127– 1129. [DOI] [PubMed] [Google Scholar]
  • 12. Roberts DK, Lo PS, Winters JE, Castells DD, Alexander CC, Teitelbaum BA. . Prevalence of pigmented lens striae in a black population: a potential indicator of age-related pigment dispersal in the anterior segment. Optom Vis Sci. 2002; 79: 681– 687. [DOI] [PubMed] [Google Scholar]
  • 13. Roberts DK, Winters JE, Castells DD, Clark CA, Teitelbaum BA. . Pigmented striae of the anterior lens capsule and age-associated pigment dispersion of variable degree in a group of older African-Americans: an age, race, and Sex matched study. Int Ophthalmol. 2001; 24: 313– 322. [DOI] [PubMed] [Google Scholar]
  • 14. Roberts DK, Ayyagari R, McCarthy B, Xie H, Davis F, Wilensky JT. . Investigating ocular dimensions in African Americans with long anterior zonules. J Glaucoma. 2013; 22: 393– 397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Roberts DK, Newman TL, Roberts MF, Wilensky JT. . Remnants of the anterior tunica vasculosa lentis and long anterior lens zonules. J Glaucoma. 2014; 23: 441– 445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Assia EI, Apple DJ, Tsai JC, Morgan RC. . Mechanism of radial tear formation and extension after anterior capsulectomy. Ophthalmology. 1991; 98: 432– 437. [DOI] [PubMed] [Google Scholar]
  • 17. Blumenthal M, Assia E, Schochot Y. . Lens anatomical principles and their technical implications in cataract surgery. Part I: The lens capsule. J Cataract Refract Surg. 1991; 17: 205– 210. [DOI] [PubMed] [Google Scholar]
  • 18. Chen SD, Glover N, Patel CK. . Trypan blue staining of anteriorly placed zonules in patients with pigment dispersion. J Cataract Refract Surg. 2004; 30: 2462– 2463. [DOI] [PubMed] [Google Scholar]
  • 19. Kelty PJ, Snyder ME, Schneider S. . Indocyanine green staining of anteriorly placed zonules. J Cataract Refract Surg. 2003; 29: 2229– 2231. [DOI] [PubMed] [Google Scholar]
  • 20. Koch DD, Liu JF. . Zonular encroachment on the anterior capsular zonular-free zone. Am J Ophthalmol. 1988; 106: 491– 492. [DOI] [PubMed] [Google Scholar]
  • 21. Masket S. . Postoperative complications of capsulorhexis. J Cataract Refract Surg. 1993; 19: 721– 724. [DOI] [PubMed] [Google Scholar]
  • 22. Stark WJ, Streeten B. . The anterior capsulotomy of extracapsular cataract extraction. Ophthalmic Surg. 1984; 15: 911– 917. [PubMed] [Google Scholar]
  • 23. Roberts DK, Yang Y, Morettin CE, Doan T, Newman TL, Wilensky JT. . Quantification of long anterior lens zonules and their resulting zonule-free zone sizes. Clin Exp Ophthalmol. 2015; 43: 773– 775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Roberts DK, Yang Y, Wilensky JT. . Cataract surgery in African Americans with long anterior lens zonules. Clin Experiment Ophthalmol. 2014; 42: 898– 900. [DOI] [PubMed] [Google Scholar]
  • 25. Roberts DK, Ayyagari R, Moroi SE. . Possible association between long anterior lens zonules and plateau iris configuration. J Glaucoma. 2008; 17: 393– 396. [DOI] [PubMed] [Google Scholar]
  • 26. Stankovic M, Stankovic I. . Les lignes pigmentées épicapsulaires du cristallin (Vogt) et le glaucome. Bulletins et Memoires de la Societe Francaise D'Ophthalmologie. 1962; 75: 586– 595. [Google Scholar]
  • 27. Hayward C, Shu X, Cideciyan AV,et al. Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration. Hum Mol Genet. 2003; 12: 2657– 2667. [DOI] [PubMed] [Google Scholar]
  • 28. Katoh M. . Molecular cloning and characterization of MFRP, a novel gene encoding a membrane-type Frizzled-related protein. Biochem Biophys Res Commun. 2001; 282: 116– 123. [DOI] [PubMed] [Google Scholar]
  • 29. Roberts DK, Teitelbaum BA, Castells DD, Winters JE, Wilensky JT. . Anterior chamber depth, lens thickness, and related measures in African American females with long anterior zonules: a matched study with control for refractive error. J Glaucoma. 2016; 25: 45– 48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Roberts DK, Yang Y, Morettin CE, Newman TL, Roberts MF, Wilensky JT. . Morphologic patterns formed by the anomalous fibers occurring along the anterior capsule of the crystalline lens in people with the long anterior zonule trait. Anat Rec (Hoboken). 2017; 300: 1336– 1347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Hogan MJ, Alvarado JA, Weddell JE. . Histology of Human Eye: An Atlas and Textbook. Philadelphia, PA: W.B. Saunders; 1971. [Google Scholar]
  • 32. Roberts DK, Wilensky J. . Long anterior lens zonules. Clin Experiment Ophthalmol. 2012; 40: 764– 766. [DOI] [PubMed] [Google Scholar]
  • 33. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998; 158: 1855– 1867. [DOI] [PubMed] [Google Scholar]
  • 34. Leske MC, Heijl A, Hussein M,et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003; 121: 48– 56. [DOI] [PubMed] [Google Scholar]
  • 35. Gordon MO, Beiser JA, Brandt JD,et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120: 714– 720. [DOI] [PubMed] [Google Scholar]
  • 36. Klein BE, Klein R. . Intraocular pressure and cardiovascular risk variables. Arch Ophthalmol. 1981; 99: 837– 839. [DOI] [PubMed] [Google Scholar]
  • 37. Shiose Y. . Intraocular pressure: new perspectives. Surv Ophthalmol. 1990; 34: 413– 435. [DOI] [PubMed] [Google Scholar]
  • 38. Ganley JP. . Epidemiological aspects of ocular hypertension. Surv Ophthalmol. 1980; 25: 130– 135. [DOI] [PubMed] [Google Scholar]
  • 39. Tomlinson A, Phillips CI. . Applanation tension and axial length of the eyeball. Br J Ophthalmol. 1970; 54: 548– 553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Weih LM, Mukesh BN, McCarty CA, Taylor HR. . Association of demographic, familial, medical, and ocular factors with intraocular pressure. Arch Ophthalmol. 2001; 119: 875– 880. [DOI] [PubMed] [Google Scholar]
  • 41. Klein BE, Klein R, Linton KL. . Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992; 33: 2224– 2228. [PubMed] [Google Scholar]
  • 42. Ramdas WD, Wolfs RC, Hofman A, de Jong PT, Vingerling JR, Jansonius NM. . Lifestyle and risk of developing open-angle glaucoma: the Rotterdam study. Arch Ophthalmol. 2011; 129: 767– 772. [DOI] [PubMed] [Google Scholar]
  • 43. Kahn HA, Leibowitz HM, Ganley JP,et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 1977; 106: 33– 41. [DOI] [PubMed] [Google Scholar]
  • 44. Leske MC, Podgor MJ. . Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol. 1983; 118: 280– 287. [DOI] [PubMed] [Google Scholar]
  • 45. Dielemans I, Vingerling JR, Algra D, Hofman A, Grobbee DE, de Jong PT. . Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology. 1995; 102: 54– 60. [DOI] [PubMed] [Google Scholar]
  • 46. Williams BI, Peart WS, Letley E. . Abnormal intraocular pressure control in systemic hypertension and diabetic mellitus. Br J Ophthalmol. 1980; 64: 845– 851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. . Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 1995; 102: 48– 53. [DOI] [PubMed] [Google Scholar]
  • 48. Yip JL, Aung T, Wong TY,et al. Socioeconomic status, systolic blood pressure and intraocular pressure: the Tanjong Pagar Study. Br J Ophthalmol. 2007; 91: 56– 61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Wu SY, Leske MC. . Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol. 1997; 115: 1572– 1576. [DOI] [PubMed] [Google Scholar]
  • 50. Lee AJ, Rochtchina E, Wang JJ, Healey PR, Mitchell P. . Does smoking affect intraocular pressure? Findings from the Blue Mountains Eye Study. J Glaucoma. 2003; 12: 209– 212. [DOI] [PubMed] [Google Scholar]
  • 51. al-Tweigeri T, Nabholtz JM, Mackey JR. . Ocular toxicity and cancer chemotherapy. A review. Cancer. 1996; 78: 1359– 1373. [DOI] [PubMed] [Google Scholar]
  • 52. Fabre-Guillevin E, Tchen N, Anibali-Charpiat MF, Calluaud L, Ravaud A. . Taxane-induced glaucoma. Lancet. 1999; 354: 1181– 1182. [DOI] [PubMed] [Google Scholar]
  • 53. Hazin R, Abuzetun JY, Daoud YJ, Abu-Khalaf MM. . Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients. Curr Opin Ophthalmol. 2009; 20: 308– 317. [DOI] [PubMed] [Google Scholar]
  • 54. Huillard O, Bakalian S, Levy C,et al. Ocular adverse events of molecularly targeted agents approved in solid tumours: a systematic review. Eur J Cancer. 2014; 50: 638– 648. [DOI] [PubMed] [Google Scholar]
  • 55. Schmid KE, Kornek GV, Scheithauer W, Binder S. . Update on ocular complications of systemic cancer chemotherapy. Surv Ophthalmol. 2006; 51: 19– 40. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1

Articles from Investigative Ophthalmology & Visual Science are provided here courtesy of Association for Research in Vision and Ophthalmology

RESOURCES